Sign in

    Howard Halperin • Taglich Brothers

    Howard Halpern is Principal Equity Analyst at Taglich Brothers, specializing in coverage of the healthcare and biotechnology sectors with a focus on small- and micro-cap companies such as Ocean Biomedical and BGSF, Inc. His performance metrics indicate a 0% published success rate and an average return of -72.91% on recorded stock recommendations, ranking him near the bottom among Wall Street analysts based on tracked data. Halpern has held his current role at Taglich Brothers for several years, with his earliest tracked rating at the firm dating back to 2015 and research updates continuing through 2025; previous professional experience is inferred from his longstanding tenure, though specific prior firms are not publicly detailed. As a senior research analyst and principal, he is likely FINRA registered and holds standard securities licenses required for equity analysts, although specific licenses are not explicitly listed in available public profiles or databases.

    Howard Halperin's questions to Bridgeline Digital Inc (BLIN) leadership

    Howard Halperin's questions to Bridgeline Digital Inc (BLIN) leadership • Q3 2025

    Question

    Howard Halperin of Taglich Brothers inquired about the evolution of Bridgeline's customer acquisition strategy, the composition of the sales pipeline between new and existing customers, and customer feedback on recent technology enhancements.

    Answer

    President & CEO Ari Kahn explained that the company has shifted its marketing approach to invest two-thirds of its budget into known, effective campaigns, a reversal from its previous experimental strategy. Kahn highlighted that 60% of sales are to existing customers, which demonstrates product value and reduces acquisition costs. He also confirmed that most new product features, such as multi-site management and advanced analytics, are directly driven by customer feedback gathered by Bridgeline's professional services and customer success teams.

    Ask Fintool Equity Research AI